ssential hypertension has a high prevalence among blacks, 1 appears to have a genetic basis, 2 and by definition, has no known cause. However, both Guyton 3 and Bianchi et al. 4 have suggested that the kidney is primarily at fault in essential hypertension. Essential hypertension tends to cause kidney damage (nephrosclerosis) more frequently among blacks than whites 5 and may be responsible for the disproportionate numbers of blacks who have end-stage renal disease. 6 Support has been lent to the theory of the primacy of the kidney in the pathogenesis of essential hypertension by the confirmed observation 7, 8 that spontaneously hypertensive rats will become normotensive after removal of their native kidneys and transplantation with a kidney from a normotensive rat. The purpose of the current report is to demonstrate that this phenomenon also occurs in human beings; thus, black patients with essential hypertension associated with nephrosclerosis and eventual renal failure can become and remain normotensive when they receive an immunologically well-tolerated kidney allograft from a normotensive donor.
Methods
Six patients were selected from our transplant clinic for detailed study in our General Clinical Research Center because there was good evidence that essential hypertension leading to nephrosclerosis was the cause of their renal failure. All six had their native kidneys removed before transplantation, and renal histology and tissue blocks were available for study. All patients subsequently received a renal transplant from a normotensive living related donor (two patients) or a cadaveric donor (four patients) that provided good long-term renal function, and eventually all became normotensive without antihypertensive medications. D uring the 1970s, John Curtis and I were involved in studying mechanisms of hypertension in our post-renal transplantation patients at the University of Kentucky Medical Center. The population was predominantly Caucasian. At least 1 year after successful renal transplantation from a live related donor, patients who were receiving alternate-day steroids and who had a serum creatinine of Ͻ2 mg/dl and a bilateral nephrectomy had a prevalence of hypertension of only 6%, i.e., less than in the normal population. Thus, we were able to show that a well-tolerated transplanted kidney could sustain normotension (1) . For all patients, prevalence of hypertension was approximately 50% and the causes of hypertension were-in order of importance-chronic rejection, the native kidneys (renin-dependent hypertension), allograft renal artery stenosis, and steroid therapy.
We were aware of Guyton's work (2) suggesting the primacy of the kidney in causing essential hypertension via extracellular fluid volume expansion as the major mechanism for essential hypertension. Alternatively, one could restate the hypothesis that chronic hypertension would not be maintained in the presence of normal renal function and especially of normal excretion of sodium chloride. During Abstract Six patients in whom "essential hypertension" led to nephrosclerosis and kidney failure received kidney transplants from normotensive donors. After an average follow-up of 4.5 years, all were normotensive and had evidence of reversal of hypertensive damage to the heart and retinal vessels. These six patients, all of whom were black, and six control subjects matched for age, sex, and race were admitted to the General Clinical Research Center for 11 days for observation of their blood pressure and their responses to salt deprivation and salt loading. Mean arterial pressure (ϮS.E.M.) among the patients who had previously had essential hypertension was similar to that of the normal controls (92Ϯ1.9 vs. 94Ϯ3.9; P not significant), and both groups had similar responses to salt deprivation and salt loading. Thus, essential hypertension in human beings is shown to be similar to the hypertension seen in spontaneously hypertensive rats in that both can be corrected by transplantation of a kidney from a normotensive donor. This observation supports the concept of the primacy of the kidney in causing essential hypertension. (N Engl J Med 1983; 309:1009-15.)
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The four cadaveric donors were young (mean ϮS.E.M., 28Ϯ4 years), white, and normotensive. All four had had traumatic deaths.
All six patients were black, four were men, and the group's mean age was 40Ϯ2 years. At the time of their studies at the clinical research center the patients were receiving azathioprine (125Ϯ22 mg per day) and prednisone (16Ϯ1 mg per day) and had been followed for an average of 4.5Ϯ1.0 years (range, 1.3 to 8.0) after receiving a renal transplant.
In an effort to establish more accurately the timing of the onset of hypertension and the cause of the patients' renal failure, all available records of previous hospital stays and emergency room and doctor's office visits before transplantation at University Hospital were obtained and reviewed. The clinical histories of these six patients that led to the diagnosis of essential hypertension and nephrosclerosis are given in the Appendix. Important historical features and results of investigations that were consistent with the diagnosis of essential hypertension along with those of blood-pressure and renal-function studies the first time both were obtained simultaneously are shown in Table 1 . All University Hospital admission records were also reviewed for the six patients, and chest x-ray films, electrocardiograms, funduscopic examination notes, and blood-pressure recordings from admissions before transplantation were reviewed.
Histologic studies of the native kidneys of the six patients were reviewed by one of us (M.K.) to confirm the diagnosis of nephrosclerosis that had been made by surgical pathologists at the time of nephrectomy. In all cases neither the light-microscopical nor the ultramicroscopical studies revealed evidence of primary renal disease other than nephrosclerosis, and all the findings were consistent with nephrosclerosis as a primary cause of renal failure (Fig. 1) . The anatomic criteria for the pathological diagnosis of nephrosclerosis included generalized interstitial scarring that was accompanied by tubular loss or atrophy. The scarring was irregular, with focal large scars interspersed against a background of more diffuse scarring. The residual nephrons showed a spectrum of changes, ranging from hypertrophy to varying degrees of ischemic changes and sclerosis. The hypertrophied but otherwise normal glomeruli were associated with hyperplastic tubules, whereas sclerotic his nephrology fellowship, Dr. Curtis had spent some time with Dr. Kincaid-Smith. She is opposed to the concept that nonmalignant essential hypertension leads to hypertensive nephrosclerosis and end-stage renal disease [ESRD] and believed that a primary renal disease was much more common and much more likely; this view was based mainly on a histologic approach. In the Renal Division at the University of Kentucky Medical Center, we had weekly renal rounds that were lively and controversial and were termed "rollerball" by the residents and fellows. We were fortunate to have in the division an excellent endocrinologist with a major interest in hypertension, Dr. Ted Kotchen. He was reluctant to accept the primacy of the kidney-causing essential hypertension! We were also very interested in recurrent renal disease after transplantation and noted that systemic diseases such as a connective tissue disorder or diabetes mellitus were not "cured" by successful renal transplantation. If essential hypertension was a systemic disease that secondarily involved the kidney, then a well-tolerated allograft would not cure that disease. In contrast, if essential hypertension was due to a renal abnormality that led to hypertension, hypertensive nephrosclerosis, and end-stage kidney disease, then transplantation of a kidney that did not cause hypertension could be associated with "cure" of hypertension. We were thus challenged to find patients whose original cause for progressive renal disease was essential hypertension and whose hypertension was cured by transplantation of a normal kidney. We could not prove this sequence in Kentucky.
We were able to support this hypothesis strongly after we moved to the University of Alabama at Birmingham and began working there in Dr. Arnold Diethem's very successful and active renal transplant program. Dr. Curtis and I had never seen so many young African American patients with what clearly seemed to be essential hypertension with various stages of progression of hypertensive nephrosclerosis. Indeed, more African American patients with ESRD have received renal transplants at that medical center than anywhere else in the world. As is often the case in clinical research, we required a unique alignment of the stars in the firmament to prove the hypothesis. In addition to the large number of African American patients with well-documented essential hypertension, many of these patients had bilateral nephrectomy before transplantation. Cyclosporine was not yet in routine use; had it been, we might not have been able to carry out this study successfully because of the high prevalence of cyclosporine-induced hypertension when this agent is used after transplantation. Dr. Harriet Dustin, the famous cardiologist, was setting up a hypertension center at about this time. Dr. Curtis composed a protocol for the GCRC. Dr. Dustin's pithy review stated that "Dr. Curtis thinks about hypertension like a nephrologist." We are uncertain whether she meant this as a compliment or not! Nevertheless, Dr. Dustin enthusiastically engaged in our research, and we used her protocol to compare the response of the easily found and documented normotensive transplant patients (who had previously had essential hypertension and hypertensive nephrosclerosis) to handle sodium restriction and loading as compared with normal control subjects. The final link in our studies was the availability of histology on the removed native kidneys and of a superb nephropathologist to prove that these kidneys on detailed histologic study did not have a primary renal disease. Dr. Michael Kashgarian at Yale ably filled this role. glomeruli were accompanied by atrophic or dilated tubules containing hyaline casts. The segmental, arcuate, and interlobular arteries showed fibrous intimal thickening, with fraying, splitting, and reduplication of the internal elastic lamina. The arterioles showed hyaline thickening of the wall that frequently resulted in severe compromise of the lumen. Although the presence of some inflammatory cells was accepted as common in nephrosclerosis, only patients with inflammatory infiltrates that were focal, minimal, and chronic were considered without question to have nephrosclerosis. Two patients with a more diffuse infiltrate that could have been considered compatible with nephrosclerosis were not accepted into this category, since the possibility of chronic tubular interstitial disease could not be eliminated with complete certainty. In order to investigate further and eliminate the possibility of a primary glomerular disease, material was removed from the paraffin block in each case, and at least three glomeruli were examined by electron microscopy. No evidence of glomerular damage, other than that attributable to ischemia, was found in any of the patients. Six age-matched (40Ϯ0.5 years) and sex-matched (four men and two women), black, healthy control subjects volunteered to be admitted to the clinical research center for control studies of renal responses to salt deprivation and salt loading. All six control subjects had normal physical examinations and were taking no medications. The patients and controls gave written informed consent for the 11-day admission to the center. The purposes of this admission were to monitor blood pressure over a prolonged period and to compare the responses to high, normal, and low sodium intakes in patients who had received transplants with those in matched normal subjects. The patients and controls were placed sequentially on diets containing 150 mmol of sodium for three days (normal sodium), 9 mmol of sodium for four days (low sodium), and 9 mmol of dietary sodium plus infusions of 3.8 mmol of intravenous sodium per kilogram of body weight for three days (high sodium).
At the end of each salt-intake period the following investigations were performed: plasma renin activity was measured by radioimmunoassay in the supine position and after a 30º head-up tilt 9 ; plasma aldosterone, norepinephrine, and epinephrine levels were measured in the supine position and after a 30º head-up tilt, using a radioenzymatic assay 10, 11 ; body weight was measured; plasma volume was measured from the volume of distribution of human serum albumin, using 2.5 Ci of 125 I-labeled human serum albumin and a 10-minute equilibrium period 12 ; 24-hour creatinine clearance and urinary sodium excretion were measured daily. Mean arterial pressure was calculated daily from the diastolic blood pressure plus one third of the pulse pressure obtained from six blood-pressure measurements in the supine position. All patients also had electrocardiography and chest radiography performed during their stay in the research center.
Clinical records were reviewed for three blood-pressure measurements (immediately before dialysis) of patients one month after nephrectomy while the patients were undergoing long-term homodialysis therapy. The average of these three measurements was used as the anephric blood pressure. As noted in the Appendix, our six study patients all had their native kidneys removed shortly after nephrectomy; dialysis was used to control vascular volume and hypertension during this period.
Statistical analysis was performed by means of the paired or unpaired Student's t-test, as appropriate. A P value of less than 0.05 was considered significant.
Results
The study patients had an average mean arterial pressure of 168Ϯ9 mm Hg recorded during their first University Hospital admission before renal transplantation, at a time when each was receiving at least four different antihypertensive medications. Mean arterial pressure on Day 1 of the General Clinical Research Center admission (4.5 years after transplantation) was 92Ϯ1.9 mm Hg (P Ͻ0.001), and none of the patients was receiving antihypertensive therapy. This mean arterial pressure was not different from that of the control subjects (94Ϯ3.9 mm Hg). Both groups had normal blood-pressure recordings throughout the research-center admission, even after the three days of intravenous sodium loading (patients, 94Ϯ3.0 mm Hg, and controls, 94Ϯ6.1).
Comparison of electrocardiograms and chest x-ray films obtained before and after transplantation showed significant resolution of cardiac hypertrophy (Table 2) . Medical records We were thus able to support strongly the primacy of the kidney in essential hypertension, at least in African Americans, just like the transplant experiments in spontaneously hypertensive rats (3) . There are now numerous experiments on rodents demonstrating that hypertension moves with the kidney in transplantation experiments, but this was the first proof of this hypothesis in humans.
We subsequently studied mechanisms of hypertension caused by cyclosporine (4) and were able to demonstrate that the drug caused potent renal vasoconstriction, a less severe systemic vasoconstriction, and that the hypertension produced was sodium dependent. We postulated that cyclosporine rapidly produces hypertension-often within a week or two-and that this truncated course as compared with essential hypertension was due to the associated immediate effect of cyclosporine on the systemic vasculature to produce an elevated peripheral resistance. In contrast, studies in essential hypertension in its earliest stages show a normal peripheral resistance and an elevated cardiac output related to extracellular fluid volume expansion. Many years later in established essential hypertension, cardiac output is normal and peripheral resistance elevated.
It is gratifying to those of us who believe in the primacy of the kidney in the genesis of essential hypertension to note that all monogenetic disorders causing hypertension to date relate to enhanced renal tubular reabsorption of sodium chloride. Indeed, Dr. Curtis with Dr. Warnock subsequently showed cure of hypertension caused by Liddle's syndrome by renal transplantation in a patient in whom progressive renal disease had developed secondary to the hypertension (5). One can speculate that prevention of ESRD as a result of hypertension may be facilitated by genetic studies demonstrating both propensity to develop essential hypertension and for that hypertension to cause hypertensive nephrosclerosis.
from the University Hospital stays of all patients before transplantation contained reports of funduscopic examinations that revealed "copper-wire changes," arteriolar venous nicking, exudates, and hemorrhages. Funduscopic examination of the patients during their research-center admission revealed none of the severe hypertensive retinopathy that had been previously described in their medical records; however, findings of mild arteriolar atherosclerosis were noted in two of the six patients. These two had had the shortest follow-up after transplantation.
Changes in both body weight and 24-hour urinary excretion of sodium during the periods of different sodium intake are shown for patients and controls in Figure 2 . It should be noted that both groups "over-shot" their admission body weight after the intravenous sodium loading by very similar percentages (patients, 0.30, and controls, 0.33 per cent). Also, the patients were able to conserve sodium as well as the controls while on a diet containing 9 mmol of sodium. On the fourth day of the 9-mmol sodium diet, the patients' 24-hour urinary sodium excretion level was 10Ϯ1.2 mmol, and that for the controls was 12Ϯ1.7 mmol. Cumulative sodium balances for the entire admission also did not differ between groups. Creatinine clearance for the patients with allografts averaged 95Ϯ3 ml per minute as compared with 113Ϯ6 ml per minute for the normal, two-kidney controls (P Ͻ0.05).
Plasma volume for the two groups was also similar and changed as expected during the three different sodium-intake periods, as did plasma renin activity and aldosterone and norepinephrine levels during the different sodium-intake periods and after a 30º head-up tilt while the subjects were receiving the low-sodium diet (Table 3) . Both groups responded to sodium restriction and loading and to the tilt procedure as expected, and there were no significant differences between groups. Plasma epinephrine values were not altered by sodium intake and were
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Medizinische University Klinik Heidelberg, Germany I t is intellectually stimulating and rewarding to read past literature. One example is the relatively straightforward, meticulous, and well-documented clinical observation of Curtis et al. (1) in 1983, which is one of the milestones in clinical hypertension research and, seen in retrospect, will become a classic.
To assess the importance of this observation, it must be viewed in historical perspective. In the first half of the 20th century, investigators such as Franz Volhard and later Sir George Pickering were convinced that the kidney played an important role in the genesis of hypertension even in individuals without primary renal disease. On the basis of a quantitative and synthetic approach, i.e., systems analysis, Arthur Guyton later put this on a firm theoretical footing. He concluded that because of its high "gain," i.e., the capacity to return an aberrant pressure back toward the normal control value, the kidney, more strictly the pressure natriuresis relationship, will in the long run override all extrarenal BP and volume-regulating mechanisms. It follows that irrespective of the primary disturbance leading to hypertension, BP cannot increase unless the renal BP natriuresis relationship is altered. The primary defect in essential hypertension has not been clarified, but according to Guyton, functional or structural (3) abnormalities of the kidney must play a central role.
This idea gained further momentum when transplantation experiments in animals showed that BP "goes with the kidney" (4, 5) . These experiments are technically very demanding, because the outcome is easily confounded by arterial or ureteral stenosis, ischemia reperfusion injury, or immune damage to the graft. The most convincing evidence had come from the study of Rettig et al. (6) , who transplanted kidneys of spontaneously hypertensive rats (SHR) into hybrid recipients that were unable to mount a rejection against the graft. In the recipients, the central and peripheral nervous system, the volume-regulatory systems, the heart, and the vascular system all were genetically programmed for normotension.
Nevertheless, the presence of a kidney that was genetically programmed for hypertension was able to override all control systems and impose hypertension on an originally normotensive recipient. These results are particularly impressive, because, at least in later studies, hypertensioninduced damage of the graft had been carefully avoided by antihypertensive treatment of the prehypertensive donor animals starting from weaning. It proved more difficult to show that transplantation of a graft derived from a normotensive donor rat is able to lower BP in a hypertensive rat, but ,ultimately, this also has been documented (7) .
Against this background, the clinical observation of Curtis was of particular importance as proof of the principle The bars on the left represent the amount of sodium intake and urinary sodium excretion at the end of each different sodium diet. The control group (CG) received a slightly larger sodium load than the study patients (EHTX) because of their slightly greater body weight (3.8 mmol of sodium per kilogram of body weight). There were no statistically significant differences between groups in amount of sodium excretion during the three different intake periods. The bars on the right indicate the percentage change in body weight for the two groups at the end of the periods of low and high intake of sodium. The line marked "100%" represents the group's body weight on admission. Again, both groups responded similarly.
similar for both groups (40.0Ϯ11.6 vs. 24.3Ϯ5.5 pg per milliliter; P not significant). Both groups also responded to the tilt procedure with similar increases in plasma epinephrine levels (ϩ16.5Ϯ5.6 vs. ϩ16.8Ϯ7.8 pg per milliliter; P not significant).
Discussion
We have described six patients who had strong clinical and histologic evidence of essential hypertension and nephrosclerosis as a cause of end-stage renal disease, along with evidence of other end-organ damage from the hypertension. One to eight years after successful transplantation, all had blood-pressure measurements that, despite prednisone therapy, were not different from those of six normotensive subjects. Moreover, all had evidence of reversal of end-organ damage. We believe that these observations support Guyton's and Bianchi's contention that, at least in some patients, the kidney is primarily at fault in essential hypertension. 3, 4 We and others [13] [14] [15] have previously reported the dramatic reversal of hypertension that occurs in some patients with endstage renal disease after successful renal transplantation. However, there was no documentation in these reports that the patient's original disease was essential hypertension and nephrosclerosis. Nephrosclerosis is a diagnosis that is not easily documented. 16 Since hypertension develops in most patients with other forms of primary renal disease (so-called secondary hypertension) and since most nephrologists do not perform renal biopsies in patients in whom they suspect nephrosclerosis, it is difficult to prove that some other occult primary renal disease was not the true cause of both the hypertension and renal failure. Our six patients were selected because all had histologic examinations of their native kidneys and strong clinical histories to support the diagnosis of nephrosclerosis and to rule out other causes of renal failure. Only black patients whose age at onset of hypertension was characteristic of that for essential hypertension were selected. Moreover, all were documented to have low levels of urinary protein excretion that were consistent with essential hypertension, and most were observed to have hypertension at a time when renal function, at least as judged by levels of blood urea nitrogen and creatinine, was normal. In each instance there was a family history of hypertension, and all physicians who managed their cases believed nephrosclerosis to be the correct diagnosis. This degree of documentation is not available for most of the patients in our renaltransplant clinic who are said to have nephrosclerosis. We have performed the General Research Center protocol studies in three other transplant recipients whose results we elected to exclude from this report, although their responses were similar to those of the six patients reported on, because the diagnosis that in humans, "BP goes with the kidney" as well. This observation was different from attempts to show that recipients of grafts from donors with presumed hypertension (8) or from donors coming from families with known essential hypertension (9) caused more severe hypertension in the recipient. These early observations were not simple and clearcut; they were confounded by variable renal function and use of antihypertensive agents in the recipients. Although persuasive, they failed to provide the definitive evidence.
Curtis et al. took the opposite, more straightforward approach of looking at whether transplantation of a kidney coming from a normotensive donor caused normotension in a genetically hypertensive graft recipient. The authors very carefully ensured (to the extent that this is possible in the absence of a diagnostic marker of essential hypertension) that the recipients had essential hypertension and failed to have primary renal disease. The recipients' own kidneys were subjected to careful histologic analysis, which failed to show anything but nonspecific nephrosclerosis.
The study of Curtis was carried out in the nick of time, because after the early 80s, BP in graft recipients is usually elevated to some extent because of the use of calcineurin inhibitors, which cause hypertension even in recipients of nonrenal grafts (10) . However, the use of a kidney graft is not as clearcut a model as one would like to have it. Denervation of the graft is a potential confounder. Experimental (11) and clinical (12) studies showed that in the damaged kidney, activation of chemoreceptors and/or mechanoreceptors generates stimulatory signals that activate the hypothalamus and increase efferent sympathetic traffic. The potential role of renal nerves on the development of hypertension has been shown in elegant denervation experiments in models of hypertension that do not involve renoparenchymal damage (13) .
Against the background of Guyton's hypothesis (1), Curtis et al. went to great lengths to show that handling of salt and volume loads was normal in the recipients of the normotensive grafts. They provided convincing evidence that-compared with normal controls-graft recipients had similar responses to salt deprivation and salt loading. Curtis et al. had remained appropriately cautious as to the exact cause, i.e., whether the primary defect is intrinsic to the kidney or the result of faulty interaction of the kidney with extrarenal signals, e.g., hypothetical natriuretic substances.
The general conclusion of Curtis et al. that renal functional abnormalities must play a role in the genesis of essential hypertension is in line with some studies that documented abnormalities of renal hemodynamics in "prehypertensive" individuals, i.e. offspring of hypertensive parents who had not (yet) developed hypertension (14, 15) . Unfortunately, these studies differ in important details, so their interpretation is difficult.
There is another aspect to the observation of Curtis et al. that deserves comment. The idea has been advanced that once hypertension has been sufficiently severe and has been present for a prolonged time, vascular remodeling will raise peripheral vascular resistance and maintain elevated BP, providing an element of self-perpetuating hypertension (16) . The observation of Curtis et al. is encouraging in this respect by showing that, at least in the long run and in relatively young individuals, such vascular adaptations are functionally reversible. of nephrosclerosis was less certain. One patient was a white woman, 38 years of age, with clinical and histologic evidence of essential hypertension; she was excluded for epidemiologic reasons. The other two were black men with strong clinical histories who were thought by our surgical pathologists to have nephrosclerosis; however, one of us (M.K.), in reviewing their renal histologic studies, believed that some form of occult, primary, interstitital renal disease could not absolutely be excluded, since a diffuse infiltrate of lymphocytes was present.
Thus, this study provides no estimate of the fraction of patients with essential hypertension and nephrosclerosis who become normotensive after renal transplantation. Although we attempted to select for our study only black patients with strong clinical histories of nephrosclerosis who had renal tissue available for study and excellent allograft function, this does not necessarily mean that the diagnosis of nephrosclerosis in our other patients was wrong. We have been following 360 patients in our renal-transplant clinic, and 81 of these (22 per cent) were said to have nephrosclerosis as their original disease. Of these 81 patients, 33 had been followed at this writing for at least one year after transplantation, had had their native kidneys removed, and had well-functioning allografts (serum creatinine Ͻ 2.0 mg per deciliter [180 mol per liter]). Of these 33 patients with the clinical diagnosis of nephrosclerosis, 8 (24 per cent) still required antihypertensive medications, and the other 25 (76 per cent) were normotensive. This is the same percentage (24 per cent) of hypertensive patients that we observed previously 14 in a group of transplant recipients with primary renal disease, although the groups are not directly comparable. Although the clinical diagnosis of nephrosclerosis in this group of 33 may not be as certain as in our six study patients, they do provide an estimate of the percentage of such patients who become normotensive after successful transplantation.
The observation that a number of patients with nephrosclerosis remain hypertensive after transplantation would not invalidate this report, since it has been well documented that even in the unusual patients who never had hypertension before transplantation, hypertension may develop after transplantation. 15 The causes of such post-transplant hypertension include chronic rejection of the allograft, 17 stenosis of the transplanted renal artery, 18 steroid therapy, 19 and the presence of native, diseased kidneys. 20 Reports of the likelihood that hypertension will develop after transplantation suggest no correlation with the original kidney disease. [21] [22] [23] Thus, only the finding of normal blood pressure in patients in whom endstage renal disease developed because of nephrosclerosis is useful in support of Guyton's hypothesis; the finding of hypertension would neither support nor detract from the proposition.
Bright was the first to suggest that the kidney was the organ primarily responsible for causing damage to other organs through a mechanism about which he hesitated to speculate. 24 At the time neither the concept of measuring blood pressure nor the means to do so were available. Forty-five years later, Mahomed described "chronic Bright's disease without albuminuria." 25 In 1911 Frank coined the term "essential hypertonia" to describe the condition of similar patients. 26 Since no obvious renal disease (albuminuria) was seen in these patients, Bright's suggestion that the kidney was the organ primarily responsible for causing damage to the others was given less weight, and many saw the kidney as just another "end organ" that was being damaged by the hypertension. A recent study by Feld et al. 27 in which medical treatment was used to prevent the development of hypertension in spontaneously hypertensive What are the implications for hypertension in renal disease? Although numerous studies in essential hypertension document abnormalities in the function of the CNS, the activity of the sympathetic and parasympathetic autonomous nerve system, or the function of volume control, the study of Curtis et al. proves that the kidney is both necessary and sufficient to cause hypertension or normotension, respectively. If the kidney is indispensable for the development of essential hypertension in individuals without intrinsic renal disease, then it is less surprising that hypertension is such an early (17) and constant feature in patients with primary renal disease.
What is the general relevance of the observation of Curtis today? One of the most important functions of the clinical investigator is to provide robust data based on which he can formulate plausible working hypotheses on potential pathomechanisms. Although the observation of Curtis did not directly identify a smoking gun, it identified faulty renal mechanisms as a necessary step in the genesis of essential hypertension. This allows one to propose, for instance, one reasonable testable working hypothesis, i.e., that the epithelial sodium channel malfunction may be involved in the genesis of essential hypertension. In this context, it is of interest that all monogenic forms of hypertension identified so far concern renal tubular sodium transport. In this perspective, the study of Curtis et al. is an illustration of the more general principle of how medical progress is achieved. The facts must be firmly established by careful observations and testable working hypotheses must be formulated, and these in turn must be subjected to falsification (or lack thereof) by appropriate experiments-a scientific strategy brilliantly outlined by the late philosopher Karl Popper (1902-1994). rats demonstrated that, despite control of blood pressure, renal lesions eventually developed in such rats that were identical to those that developed in spontaneously hypertensive rats that were allowed to become hypertensive. The authors concluded that hypertension was not the cause of the renal lesions, but rather that they were due to a genetic defect in the vessels of the rats' kidneys. The present study also suggests that, at least in this subgroup of patients with essential hypertension, the primary defect must lie within the kidney or must involve some pathophysiologic relation between another organ, a humoral agent, or the sympathetic nervous system and the patient's kidneys that does not exist with the transplanted kidney. Of course, our findings are limited, in that the longest patient follow-up has only been for eight years. It is possible that the pathogenetic mechanisms of essential hypertension are not found solely in the kidney, but require longer periods of follow-up to become evident again. However, these findings strongly support the need for a continuing search for early abnormalities of renal function or structure or both in essential hypertension.
Appendix

Case 1
The patient, a 39-year old black man, was first told he had hypertension in 1971 but was not treated at that time. He had severe morning headaches beginning in 1972 and was admitted to University Hospital with a blood pressure of 240/170 mm Hg. After blood-pressure control, his hospital evaluation included chest radiography and electrocardiography, the results of which suggested left ventricular hypertrophy. Funduscopic examination demonstrated the presence of arteriolar venous nicking, arteriolar narrowing, hemorrhages, and exudates but no papilledema. Urinalysis revealed that the urine had a specific gravity of 1.030 and was otherwise normal. The 24-hour urinary excretion of protein was 100 mg. The blood urea nitrogen level was 13 mg per deciliter (4.6 mmol per liter), and the creatinine 1.3 mg per deciliter (110 mol per liter). Creatinine clearance was 90 ml per minute. The intravenous pyelogram and renal arteriogram were normal, as were the serum potassium level and the results of urine tests for metanephrines. There was a family history of hypertension that included a father who had died at age 38 from "severe hypertension." The patient's mother was taking antihypertensive medications. The patient was discharged from the hospital with a diagnosis of essential hypertension; he was to have been followed by the cardiology clinic, but he did not visit the clinic.
In 1974 the patient was seen in the emergency room of University Hospital because of epistaxis. At that time his blood pressure, during treatment with antihypertensive medications, was 160/120 mm Hg, his blood urea nitrogen level was 18 mg per deciliter (6.4 mmol per liter), and his serum creatinine level was 1.4 mg per deciliter (120 mol per liter). In 1975 he was hospitalized because of a bleeding duodenal ulcer and underwent vagotomy and pyloroplasty. On that admission, his blood pressure was 140/100 mm Hg during treatment with antihypertensive medications. His blood urea nitrogen level was 18 mg per deciliter (6.4 mmol per liter), and his creatinine 1.2 mg per deciliter (110 mol per liter).
Nine months later the patient returned to the emergency room with severe headaches and was found to have a blood pressure of 260/165 mm Hg, a blood urea nitrogen level of 46 mg per deciliter (16 mmol per liter), and a creatinine level of 4.2 mg per deciliter (370 mol per liter). He refused admission but returned five days later with a blood urea nitrogen level of 55 mg per deciliter (20 mmol per liter) and a creatinine level of 6.5 mg per deciliter (570 mol per liter). After admission to the hospital, his blood pressure was controlled, but his renal function did not improve, and he required hemodialysis. His first dialysis treatment was in January 1976. In February, a bilateral nephrectomy was performed for hypertension. The mean arterial pressure (ϮS.E.M.), based on three measurements one month after nephrectomy, was 113Ϯ3 mm Hg at a time when the patient was undergoing long-term dialysis. He was evaluated for renal transplantation, and one of his brothers (age 40) was hospitalized as a possible donor but found to be hypertensive. In March 1976, the patient received a cadaver renal transplant and did well. He was hospitalized in the General Clinical Research Center six years later for studies. His blood pressure on admission was 120/80 (mean arterial pressure, 93.3 mm Hg) without antihypertensive medications.
Case 2
The patient was a 44-year-old black man who was in apparent good health until 1973, when he became short of breath and entered a local hospital. He was found to have a blood pressure of 180/150 mm Hg. Clinical signs of congestive heart failure were present, and chest x-ray films and an electrocardiogram demonstrated the presence of left ventricular hypertrophy. The patient's blood pressure was controlled, and his congestive heart failure improved. His hematocrit was 44 per cent, serum potassium 4 mmol per liter, serum calcium 9 mg per deciliter (2 mmol per liter), and serum phosphorus 4.5 mg per deciliter (1.5 mmol per liter). The urine was normal (without protein by dipstick), and serum albumin was 4 g per deciliter (580 mol per liter). The blood urea nitrogen level was 23 mg per deciliter (8.2 mmol per liter), and the serum creatinine level 1.7 mg per deciliter (150 mol per liter). Hypertensive intravenous pyelography was performed with normal results. The patient was discharged to be followed by the clinic, but he did not return until one year later (1974), when he had nausea and vomiting and returned to the same hospital. At that time his blood pressure was 160/120, the blood urea nitrogen level was 70 mg per deciliter (25 mmol per liter), and the creatinine level was 12 mg per deciliter (106 mol per liter). The 24-hour urinary excretion of protein was 600 mg. With blood-pressure control, renal function did not improve, and the patient was transferred to University Hospital for dialysis therapy. He had 11 siblings, 8 of whom were hypertensive and receiving medical therapy. His father died at the age of 35 (cause unknown), and his mother, who was hypertensive, died at 68. He began receiving long-term dialysis in 1975, two years after his first admission for hypertension. His native kidneys were removed because of hypertension. His blood pressure was much more easily managed after nephrectomy; mean arterial pressure was 96Ϯ5 mm Hg while the patient was undergoing long-term dialysis. In 1977 he received a cadaver renal transplant and did well. Five years after transplantation he was admitted to the clinical research center for studies. His blood pressure was 115/80 (mean arterial pressure, 91.7 mm Hg) without antihypertensive medications.
Case 3
The patient was a 38-year-old black woman who first noted to have hypertension during her fourth pregnancy in 1974. She required antihypertensive therapy during the pregnancy, which terminated in a stillbirth. Her physician directed her to take antihypertensive medications when she left the hospital. No record of renal-function tests during this hospitalization are available.
The patient reported that she did not take the prescribed antihypertensive medications, and one-year later (1975) she saw another physician who noted that her blood pressure was 150/100 mm Hg. On that office visit she had a normal urinalysis, a blood urea nitrogen level of 12 mg per deciliter (4.3 mmol per liter), and a creatinine level of 1.0 mg per deciliter (88 mol per liter). She again received prescriptions for antihypertensive medications, but she did not take the medications.
Five years later (1980), the patient had nausea and vomiting and was hospitalized in Selma, Alabama. She was found again to have hypertension and renal failure and was transferred to Montgomery, Alabama, for dialysis therapy. Several months later, she was referred to University Hospital for a bilateral excision of her native kidneys because her blood pressure was being poorly controlled with dialysis. She was also evaluated for a possible renal transplant on that admission. Her blood pressure on admission was 230/110 mm Hg; funduscopic examination revealed the presence of arteriolar venous nicking and copper-wire changes. An electrocardiogram and chest x-ray films demonstrated the presence of left ventricular hypertrophy. The urine was without abnormal protein, and 24-hour urinary excretion of protein was less than 100 mg. The patient's father had been hypertensive and died at age 40 of a cerebral vascular accident. Her mother was hypertensive and receiving therapy as was her 32-year-old brother. Her three sisters, however, had normal blood pressure. Despite her bilateral nephrectomy, the patient's blood pressure proved difficult to control with long-term dialysis. One month after nephrectomy, the mean arterial pressure was 138Ϯ4 mm Hg, despite therapy with propranolol (120 mg four times daily), hydralazine (50 mg three times daily), and dialysis. In October 1980, a renal-transplant operation was performed with a kidney from the patient's 31-year-old sister. The graft functioned well, and the patient was admitted to the clinical research center 1.3 years later for studies. Her blood pressure was 120/70 mm Hg (mean arterial pressure, 86.7 mm Hg) without antihypertensive medications.
Case 4
The patient was a 33-year-old black man who was first told he had hypertension in 1966 during a physical examination for the armed forces. He did not receive therapy for his hypertension until 1976, when he was seen in a local emergency room for a laceration on his arm and was again found to be hypertensive. For six months his blood pressure was controlled with antihypertensive medications, but headaches developed and he was seen at a local emergency room with a blood pressure of 188/120 mm Hg. He was admitted to that hospital and found to have left ventricular hypertrophy by chest radiography and electrocardiography; arteriolar narrowing and exudates were seen on funduscopic examinations. His serum potassium level was 4 mmol per liter, his blood urea nitrogen level was 35 mg per deciliter (12 mmol per liter), and urinalysis was negative for protein. His blood pressure was better controlled with increases in his antihypertensive medications, and he was referred to Vanderbilt University Hospital for evaluation of the cause of his hypertension. At Vanderbilt, he underwent intravenous pyelography and renal arteriography, the results of both of which were normal. Urinalysis revealed trace protein, and the 24-hour urinary protein excretion level was 500 mg. The 24-hour urinary excretion of catecholamines was also normal. The blood urea nitrogen level was 39 mg per deciliter (14 mmol per liter), and the patient was seen in consultation by members of the nephrology service, who thought his longstanding hypertension, low level of proteinuria, and normal-size kidneys were consistent with nephrosclerosis and recommended that he not undergo renal biopsy. The patient's mother and father were both hypertensive and required medication. One sister (age 30) was also taking antihypertensive medications, and a brother (age 23) had been told he was hypertensive and given prescriptions for medications.
The patient's antihypertensive medications were adjusted at Vanderbilt, and he was discharged in 1976 with a diagnosis of essential hypertension, to be followed by his local physician. In 1978 he saw his physician again, admitted he had not taken his medications, and was noted to have a blood urea nitrogen level of 129 mg per deciliter (46.1 mmol per liter) and a creatinine level of 19 mg per deciliter (1700 mol per liter). His blood pressure was 200/130 mm Hg, and he was started on hemodialysis therapy. A bilateral nephrectomy was performed because the blood pressure could not be adequately controlled on dialysis. One month after nephrectomy, blood-pressure control was improved. Mean arterial pressure was 113Ϯ3 mm Hg on long-term dialysis. One year later (1979), the patient received a cadaver renal transplant and did well. Three years later he was admitted to the clinical research center for studies. His blood pressure was 125/80 mm Hg (mean arterial pressure, 95 mm Hg) without antihypertensive medications.
Case 5
The patient was a 45-year-old black woman who was first told she had hypertension in 1965 but was not given antihypertensive therapy at that time. Records of her sixth pregnancy were not available, but she was said to have become hypertensive without edema and had a "stillbirth" She was admitted to University Hospital in 1975 during her seventh pregnancy when she was noted to have a blood pressure of 150/100 mm Hg. Her blood urea nitrogen level was 10 mg per deciliter (3.6 mmol per liter), and her serum creatinine level was 0.4 mg per deciliter (35 mol per liter). The 24-hour urinary protein excretion level was 360 mg, and creatinine clearance was 155 ml per minute. The patient's blood pressure was controlled with medications, and she had a normal delivery.
She continued to take her antihypertensive medications for nearly a year after the pregnancy but then discontinued them on her own. Two years later (1978) she was seen at a local hospital with a blood pressure of 230/130 mm Hg, a blood urea nitrogen level of 92 mg per deciliter (33 mmol per liter), and a serum creatinine level of 16 mg per deciliter (1400 mol per liter). She was then referred to the University Hospital for long-term hemodialysis. The patient's mother and father both had hypertension and were taking antihypertensive medications. Two sisters were hypertensive and being treated, and two others had normal blood pressure. The patient underwent a bilateral nephrectomy for blood-pressure control soon after beginning dialysis; however, mean arterial pressure remained elevated at 126Ϯ10 mm Hg despite therapy with propranolol (80 mg twice daily), prazosin (2 mg daily), and dialysis. She received a renal transplant from her sister three months after beginning dialysis. She did well and was admitted to the clinical research center four years later for studies; her blood pressure at that time was 125/75 mm Hg (mean arterial pressure, 91.7 mm Hg) without antihypertensive medications.
Case 6
The patient was a 31-year-old black man with congenital blindness resulting from glaucoma. He was well and did not visit a physician until 1974, when he went to a local emergency room with a severe headache and lethargy. His blood pressure was found to be 300/160 mm Hg, and he was admitted to the hospital. His blood urea nitrogen level was 28 mg per deciliter (9.9 mmol per liter), creatinine level 2.8 mg per deciliter (250 mol per liter), and hematocrit 38 per cent. The serum potassium level was 4.5 mmol per liter. The 24-hour urinary protein excretion level was 600 mg. Intravenous pyelography revealed normal-sized kidney's without evidence of renal vascular disease. Despite therapy, the patient's blood pressure proved difficult to control, and two months after the first onset of symptoms he was referred to University Hospital with a serum creatinine level of 30 mg per deciliter (2700 mol per liter). The patient was treated with hemodialysis and required a bilateral nephrectomy for blood-pressure control. Mean arterial pressure one month after nephrectomy was improved and averaged 116Ϯ6 mm Hg. The patient's mother was evaluated for possible kidney donation but was found to have hypertension, as was his 28-year-old sister. He received a cadaver renal transplant in 1974 and did well. Eight years later he was admitted to the clinical research center for studies with a blood pressure of 120/80 mm Hg (mean arterial pressure, 93.3 mm Hg) without antihypertensive medications.
